HOME >> BIOLOGY >> NEWS
New evidence on revolutionary brain pacemaker for Parkinson's Disease patients

Less than 7% of all Parkinson Disease (PD) patients across Europe that could benefit from deep brain stimulation have benefited from the Activa Parkinsons Control Therapy, despite it being the most significant advance in the treatment of Parkinsons in more than 30 years.

The European Parkinsons Disease Association (EPDA) announced today new evidence on the current uptake of deep brain stimulation for Parkinsons disease patients and despite its success there are still large numbers of patients waiting or denied access to the therapy.

Deep brain stimulation uses Medtronics Activa Parkinsons Control Therapy which is a pioneering treatment for patients with Parkinsons disease. It was launched by Medtronic with the support of the EPDA to great acclaim in Europe four years ago in 1998, however considerably low numbers of patients with Parkinsons disease have received the treatment since that period.

The World Health Organisation (WHO) has estimated that there are four million people with Parkinsons disease worldwide1. Currently Parkinsons disease is ranked as the fourth most frequent disorder of the nervous system, after epilepsy, cerebrovascular disease and Alzheimers2. It has been estimated that across Europe, approximately 20% of all PD patients could benefit from deep brain stimulation3.

However, it was revealed today that approximately 7%* of patients suitable for surgical treatment across Europe have received deep brain stimulation in the key G5 European countries (France, Italy, Germany, Spain and UK) since it was launched four years ago. Switzerland is leading the way with the UK bottom of the G5 countries in terms of accessibility to deep brain stimulation for appropriate patients. The estimated percentage of new suitable PD patients per year receiving deep brain stimulation therapy in Europe is as follows: 29.4% of patients in Switzerland, 9.8% in France, 9.3% in the Netherlands, 8.4% in Spain, 5.3% in Italy, 5.2% in Ger
'"/>

Contact: Amanda Boswell
amanda.boswell@ketchum.com
44-207-611-3571
Ketchum
25-Mar-2002


Page: 1 2 3

Related biology news :

1. New evidence of radiation risk in childhood leukaemia
2. Oldest evidence for processing of wild cereals: starch grains from barley, wheat, on grinding stone
3. Earliest evidence of hereditary genetic disorder discovered by Hebrew University researchers
4. Study finds first evidence COX-2 enzymes can regulate DNA damage
5. Researchers find evidence that sea turtles navigate with magnetic maps
6. Researchers report definitive evidence that HIV-AIDS is not from oral polio vaccine
7. Oldest known evidence of cat taming found in Cyprus, researchers report in Science
8. More evidence of major global extinctions
9. New evidence points to pollution as main cause of much coral reef destruction
10. New evidence suggests that monkey thought extinct still exists
11. Earliest evidence of humans affecting aquatic ecology in Canada, United States

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... October 02, 2018 , ... Stuart is a fun-loving eight-year-old Labrador retriever. Like many labs, ... Cynthia, “He loves playing ball so much that whenever anyone comes to our door, he ... game of fetch.” In early 2017, Stuart began limping and eventually could no longer ...
(Date:10/2/2018)... ... 2018 , ... The Federal Identity Forum & Exposition (FedID ... The Palo Alto-based face recognition company, Camvi Technologies Inc., was invited to speak ... U.S. Federal executives from Department of Defense (DoD) and Federal Bureau of Investigation ...
(Date:10/1/2018)... ... October 01, 2018 , ... NanoValent Pharmaceuticals, Inc ., ... based therapeutics, today announced the National Institute of Health (NIH) ... year funding for two separate grants. These two grants will allow NanoValent to ...
Breaking Biology News(10 mins):
(Date:9/27/2018)... ... September 26, 2018 , ... Consumers ... of their primary care physicians, according to a new Zeldis Research and Schlesinger ... doctors were asked about consumer adoption of fitness and health wearables, remote monitoring, ...
(Date:9/27/2018)... ... 2018 , ... Nvision Biomedical Technologies , a San ... at the North American Spine Society (NASS) Annual Meeting, held at the Los ... System, which received clearance from the U.S. Food and Drug Administration (FDA) in ...
(Date:9/27/2018)... ... September 27, 2018 , ... ... MA, announce today that Holotype HLA and other Omixon products will be featured ... the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... a strategic venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform ... biomarker profiling to empower clinical trials in the immuno-oncology (IO) space. , ...
Breaking Biology Technology:
Cached News: